PHI showed greater specificity for detecting prostate cancer when sensitivity was set at 80–95% and approved for men aged 50 and older with PSA levels between 4 and 10 ng/mL and normal digital rectal examination results [43,44]. This evidence concerns the gene KLK3 and prostate carcinoma.